Literature DB >> 11597037

Are conventional cardiovascular risk factors predictive of two-year mortality in hemodialysis patients?

E H Fleischmann1, J D Bower, A K Salahudeen.   

Abstract

BACKGROUND: In general population hypertension, diabetes mellitus, overweight, hyperlipidemia and smoking are well-established risk factors for cardiovascular disease. However, the effect of these conventional risk factors on cardiovascular disease and mortality of patients on hemodialysis is not well understood. Indeed, some risk factors such as high blood pressure, hyperlipidemia and excess weight have been recently claimed to correlate with improved survival.
OBJECTIVE: This study was undertaken to define the prevalence of these conventional risk factors in 453 hemodialysis patients, predominantly African-Americans, to determine their influence on two-year survival. RESULT: High cholesterol was found in 30% of the patients, high LDL-cholesterol in 25% and high triglycerides in 16%. Lipoprotein(a) (LP(a)) was elevated in 68% of the patients. 31% of our patients had predialysis mean arterial blood pressure (MAP) over 114, and 25% were obese based on a body mass index (BMI) over 30, 26% were diabetic and 25% were active smokers. Smoking was more common among our male and Caucasian patients. The aggregate score for the risk factors were 2.4+/-0.1 per patient, which increased to 3.2+/-0.1 in patients with obesity or diabetes, to 3.0+/-0.1 with hypertension and to 2.8+/-0.1 with active smoking. In multivariate Cox model analysis, prealbumin, body weight and blood pressure showed a positive correlation with two-year survival whereas diabetes mellitus had a negative correlation. Hyperlipidemia did not correlate to patients' two-year mortality. Smoking was associated with higher mortality, but that did not reach statistical significance.
CONCLUSION: Conventional risk factors at least over a two-year period do not readily account for the higher mortality of a group of predominantly African-American patients on hemodialysis. The lack of prediction is speculated to be partly due to the overriding beneficial effects of better nutrition and due to the presence of other yet to be well-defined factors such as hyperhomocysteinemia, oxidative stress, coronary calcification, hitherto unidentified uremic toxins or a combination of these factors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11597037

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  10 in total

Review 1.  Home haemodialysis and uraemic toxin removal: does a happy marriage exist?

Authors:  Raymond Vanholder; Sunny Eloot; Nathalie Neirynck; Wim Van Biesen
Journal:  Nat Rev Nephrol       Date:  2012-08-28       Impact factor: 28.314

2.  Reverse Remodeling and Prognosis Following Kidney Transplantation in Contemporary Patients With Cardiac Dysfunction.

Authors:  Nael Hawwa; Kevin Shrestha; Muhammad Hammadah; Poh Shuan Daniel Yeo; Richard Fatica; W H Wilson Tang
Journal:  J Am Coll Cardiol       Date:  2015-10-20       Impact factor: 24.094

3.  Frequency of cardiovascular risk factors and metabolic syndrome in patients with chronic kidney disease.

Authors:  Gul Sagun; Gulcin Kantarci; Banu Mesci; Sinem Gungor; Funda Turkoglu; Elif Yorulmaz; Aytekin Oguz
Journal:  Clin Med Res       Date:  2010-08-03

Review 4.  Smoking in dialysis patients: a systematic review and meta-analysis of mortality and cardiovascular morbidity.

Authors:  Scott E Liebman; Steven P Lamontagne; Li-Shan Huang; Susan Messing; David A Bushinsky
Journal:  Am J Kidney Dis       Date:  2011-06-12       Impact factor: 8.860

Review 5.  Mechanisms of cardiovascular complications in chronic kidney disease: research focus of the Transregional Research Consortium SFB TRR219 of the University Hospital Aachen (RWTH) and the Saarland University.

Authors:  Nikolaus Marx; Heidi Noels; Joachim Jankowski; Jürgen Floege; Danilo Fliser; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2018-05-04       Impact factor: 5.460

Review 6.  Cardiovascular risk factors in patients with chronic kidney disease.

Authors:  Sarina van der Zee; Usman Baber; Sammy Elmariah; Jonathan Winston; Valentin Fuster
Journal:  Nat Rev Cardiol       Date:  2009-07-21       Impact factor: 32.419

Review 7.  Assessment and management of hypertension in patients on dialysis.

Authors:  Rajiv Agarwal; Joseph Flynn; Velvie Pogue; Mahboob Rahman; Efrain Reisin; Matthew R Weir
Journal:  J Am Soc Nephrol       Date:  2014-04-03       Impact factor: 10.121

8.  Sevelamer as a phosphate binder in adult hemodialysis patients: an evidence-based review of its therapeutic value.

Authors:  Carole Nadin
Journal:  Core Evid       Date:  2005-03-31

Review 9.  How do We Manage Coronary Artery Disease in Patients with CKD and ESRD?

Authors:  Hoon Young Choi; Hyeong Cheon Park; Sung Kyu Ha
Journal:  Electrolyte Blood Press       Date:  2014-12-31

10.  Editorial on the Special Issue "Comorbidities in Chronic Kidney Disease".

Authors:  Heidi Noels; Joachim Jankowski
Journal:  Toxins (Basel)       Date:  2020-06-11       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.